In the modern world, with developed traveling facilities, tourism is an important factor in emerging new infectious diseases in non-endemic areas.
INTRODUCTION

Melioidosis is an uncommon bacterial infection caused
by Burkholderia pseudomallei (formerly Pseudomonas pseudomallei), an oxidase-positive, motile, aerobic bacillus.
It is a common endemic infection in Southeast Asia and
Northern Australia.
The main route of transmission is percutaneous inoculation; but inhalation, and rarely, ingestion are also among the routes of transmission (1) . Clinical cases of melioidosis in endemic regions are frequently seen during wet and rainy seasons and is attributed to inoculation of wounds by muddy soils (1, 2) .
The clinical spectrum of disease varies from asymptomatic illness and subclinical infection to localized involvement and septicemic cases (3) . Pneumonia is the most common presentation (2-4) and mortality rate reaches about 90% in fulminant sepsis.
We report a case of pulmonary melioidosis associated with septicemia in a 69 year-old diabetic man during a trip to Southeast Asia.
CASE SUMMARIES
A 69-year-old man was admitted due to fever, chills and lassitude from 4 days ago. He was well until 4 days ago when fever developed in the last day of his trip to Southeast Asia (Malaysia and Thailand). Then, he traveled to Dubai and after three days with fever and chills, he pseudomallei, respectively (6,7).
Pneumonia is the most common presentation of the disease and usually is marked by a high fever, headache, anorexia, and general muscle soreness. Chest pain is common, but a nonproductive or productive cough with normal sputum is the hallmark of this form of melioidosis.
Chronic suppurative infection may mimic tuberculosis, with fever, weight loss, productive cough, and upper lobe infiltrate, with or without cavitation (8).
Diabetes mellitus, excess alcohol intake, chronic renal disease and chronic lung disease, thalassemia, occupational exposure and polymorphonuclear cells dysfunction were confirmed to be significant risk factors for melioidosis and bacteremic melioidosis (9, 10) . Only diabetes mellitus was a significant factor associated with bacteremic melioidosis, as compared with non-bacteremic type (9) . In tropical northern Australia, male sex, aboriginal ethnicity and age more than 45 years are also independent predictors for melioidosis (10) .
Ceftazidime is the drug of choice for initial intensive therapy for melioidosis (11) . Addition of sulfamethoxazoletrimethoprim for neurologic, cutaneous, bone, joint and prostatic melioidosis is also recommended (12) .
Only one case of melioidosis has been reported from pseudomallei (16) .
This case is the first bacteremic case of melioidosis reported from Iran. Southeast Asia has increasing numbers of travelers from all over the world including Iran.
Therefore, regarding the relatively high prevalence of melioidosis in aforementioned area, physicians and public health providers in non-endemic countries should be alert about the possibility of disease in returning travelers.
Travelers, particularly those with risk factors including diabetes, also should be notified about the risk of melioidosis, and evade traveling during rainy seasons to the endemic areas and be careful of skin injuries.
